Effect of nicotinic adic on the composition of high density lipoprotein (HDL) and endothelial function in patients with premature coronary heart disease and elevated HDL-cholesterol.

Trial Profile

Effect of nicotinic adic on the composition of high density lipoprotein (HDL) and endothelial function in patients with premature coronary heart disease and elevated HDL-cholesterol.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 16 Feb 2013

At a glance

  • Drugs Nicotinic-acids (Primary)
  • Indications Hypercholesterolaemia; Ischaemic heart disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jan 2013 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 14 Jan 2013 Planned end date changed from 1 Mar 2013 to 1 May 2013 as reported by ClinicalTrials.gov.
    • 14 Jan 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top